PROFESSIONAL EDITION

The largest community of pharma leaders

Subscribe to Our News!

Whitepapers

      Recent Articles

      A History of Pharmaceutical Innovation In Mexico from 1950 to 2020

      Margaretta Colangelo

      Iveric Bio to Present Zimura® GATHER2 Enrollment and Retention Updates and New GATHER1 Post-Hoc Analyses Today at its Dry Age-Related Macular Degeneration Virtual Symposium...

      Industry News

      Moderna Reaffirms Commitment to Job Creation in Massachusetts

      Industry News

      Exelixis Chief Medical Officer Gisela M. Schwab, M.D., to Take Medical Leave of Absence

      Look Who’s On the Move!

      Bristol Myers Squibb Receives European Commission Approval for Onureg® (azacitidine tablets) as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia

      Regulatory Affairs

      Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in People Ages 12 and Older Who Have at Least One F508del Mutation

      Regulatory Affairs

      Cancer Diagnostics, Inc. Acquires Anatech, Ltd.

      Industry News

      CytRx Notes Orphazyme’s Regulatory Update from the FDA on Arimoclomol for Niemann-Pick Disease Type C

      Industry News

      BeiGene Announces China NMPA Approval of BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Relapsed or Refractory Waldenström’s Macroglobulinemia

      Regulatory Affairs

      Post

      Press Releases

      Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia

      Industry News

      Twelve Bio Appoints Gita Dittmar Executive Chairman

      Look Who’s On the Move!

      Vizient Announces New Membership Agreement with Leading Academic Health System

      Industry News

      Foresight Diagnostics to Present a Vision of the New Standard of Lymphoma MRD Detection at the 16th International Conference on Malignant Lymphoma

      Industry News

      Aerie Pharmaceuticals Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil Ophthalmic Solution in Japan

      Industry News

      2021 © Copyright - TPMG